Search Results - "Chieffo, N."

Seismic Damage Scenarios Induced by Site Effects on Masonry Clustered Buildings: A Case Study in South Italy by Formisano, A., Chieffo, N.

“…The present research aims to explore the influence of site effects on the seismic vulnerability of the historical centre of Baranello, a little town in the…”
Get full text

A Simplified Approach to Estimate Seismic Vulnerability and Damage Scenarios Including Site Effects. Application to the Historical Centre of Horta, Azores, Portugal by Chieffo, N., Ferreira, T. M., da Silva Vicente, R., Lourenço, P. B., Formisano, A.

“…The research attempts to provide a method for evaluating the susceptibility of heritage buildings and potential damage considering local site effects, using as…”
Get full text

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma by Leonard, JP, Friedberg, JW, Younes, A, Fisher, D, Gordon, LI, Moore, J, Czuczman, M, Miller, T, Stiff, P, Cheson, BD, Forero-Torres, A, Chieffo, N, McKinney, B, Finucane, D, Molina, A

“…Background: Galiximab is a monoclonal antibody that targets CD80, a costimulatory molecule constitutively expressed on follicular and other lymphomas. Modest…”
Get full text

A vulnerability index based-approach for the historical centre of the city of Latronico (Potenza, Southern Italy) by Chieffo, N., Formisano, A., Landolfo, R., Milani, G.

“…•The vulnerability index assessment method was extended to the historical centre made up of typical masonry aggregates.•The CARTIS methodology was applied for…”
Get full text

Multi-attribute-based procedure for seismic loss scenario in a historical area by Mascheri, G., Chieffo, N., Lourenço, P. B.

“…Seismic events have shown to be exceedingly damaging to structures over time, with serious social and economic consequences. As a result, large-scale seismic…”
Get full text

A framework for multi-risk assessment in a historical area of Lisbon by Mascheri, G., Chieffo, N., Arrighi, C., Del Gaudio, C., Lourenço, P.B.

“…Historic areas have faced escalating risks due to population growth, urbanization, climate change, and increasing public awareness. Existing risk assessment…”
Get full text

Use of “intracrine androgen signaling signature'' to predict benefit from abiraterone acetate (AA) in patients with castrate-resistant prostate cancer (CRPC) by Efstathiou, E., Tu, S., Aparicio, A., Hoang, A., Wen, S., Troncoso, P., Smith, L. A., Chieffo, N., Molina, A., Logothetis, C.

“…Abstract only…”
Get full text

Identification of an androgen withdrawal responsive phenotype in castrate resistant prostate cancer (CRPC) patients (pts) treated with abiraterone acetate (AA) by Logothetis, C. J., Wen, S., Molina, A., Chieffo, N., Smith, L. A., Troncoso, P., Efstathiou, E.

“…Abstract only…”
Get full text

V beta 17 T-cell receptor peptide vaccine. Results of a phase I dose-finding study in patients with rheumatoid arthritis by Moreland, L W, Heck, Jr, L W, Koopman, W J, Saway, P A, Adamson, T C, Fronek, Z, O'Connor, R D, Morgan, E E, Diveley, J P, Chieffo, N M

Get more information

Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis by Gottlieb, Alice B, Kang, Sewon, Linden, Kenneth G, Lebwohl, Mark, Menter, Alan, Abdulghani, Ahsan A, Goldfarb, Michael, Chieffo, Nicole, Totoritis, Mark C

“…Background: Reduction in lesional, activated T cells induces improvement in psoriatic plaques. Galiximab (IDEC-114), an IgG 1 anti-CD80 antibody, binds to…”
Get full text